Patents by Inventor Deboprosad Mondal

Deboprosad Mondal has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • AMPHETAMINE CARBAMATE COMPOUNDS AND METHODS
    Publication number: 20230286909
    Abstract: Described herein are the amphetamine-related compounds amphetamine carbamate (amphetammonium-amphetacarbamate) and amphetacarbamate, methods of making them, methods for detecting or quantitatively determining the amount of amphetacarbamate or amphetamine carbamate in a compositions, and ion chromatography columns useful in such methods.
    Type: Application
    Filed: January 18, 2023
    Publication date: September 14, 2023
    Applicant: Noven Pharmaceuticals, Inc.
    Inventor: Deboprosad Mondal
  • TRANSDERMAL AMPHETAMINE COMPOSITIONS WITH LOW LEVELS OF CARBAMATE
    Publication number: 20230201139
    Abstract: Described are methods for reducing the formation of amphetamine carbamate and amphetacarbamate in transdermal amphetamine compositions, compositions with low levels of amphetacarbamate, and methods using such compositions for transdermal delivery of amphetamine.
    Type: Application
    Filed: January 3, 2023
    Publication date: June 29, 2023
    Applicant: Noven Pharmaceuticals, Inc.
    Inventors: Atsushi Sonobe, Deboprosad Mondal, Naruhito Higo
  • Amphetamine carbamate compounds and methods
    Patent number: 11572339
    Abstract: Described herein are the amphetamine-related compounds amphetamine carbamate (amphetammonium-amphetacarbamate) and amphetacarbamate, methods of making them, methods for detecting or quantitatively determining the amount of amphetacarbamate or amphetamine carbamate in a compositions, and ion chromatography columns useful in such methods.
    Type: Grant
    Filed: January 6, 2022
    Date of Patent: February 7, 2023
    Assignee: NOVEN PHARMACEUTICALS, INC.
    Inventor: Deboprosad Mondal
  • Transdermal amphetamine compositions with low levels of carbamate
    Patent number: 11559501
    Abstract: Described are methods for reducing the formation of amphetamine carbamate and amphetacarbamate in transdermal amphetamine compositions, compositions with low levels of amphetacarbamate, and methods using such compositions for transdermal delivery of amphetamine.
    Type: Grant
    Filed: January 6, 2022
    Date of Patent: January 24, 2023
    Assignee: NOVEN PHARMACEUTICALS, INC.
    Inventors: Atsushi Sonobe, Deboprosad Mondal, Naruhito Higo
  • TRANSDERMAL AMPHETAMINE COMPOSITIONS WITH LOW LEVELS OF CARBAMATE
    Publication number: 20220218628
    Abstract: Described are methods for reducing the formation of amphetamine carbamate and amphetacarbamate in transdermal amphetamine compositions, compositions with low levels of amphetacarbamate, and methods using such compositions for transdermal delivery of amphetamine.
    Type: Application
    Filed: January 6, 2022
    Publication date: July 14, 2022
    Applicant: NOVEN PHARMACEUTICALS, INC.
    Inventors: Atsushi Sonobe, Deboprosad Mondal, Naruhito Higo
  • AMPHETAMINE CARBAMATE COMPOUNDS AND METHODS
    Publication number: 20220213029
    Abstract: Described herein are the amphetamine-related compounds amphetamine carbamate (amphetammonium-amphetacarbamate) and amphetacarbamate, methods of making them, methods for detecting or quantitatively determining the amount of amphetacarbamate or amphetamine carbamate in a compositions, and ion chromatography columns useful in such methods.
    Type: Application
    Filed: January 6, 2022
    Publication date: July 7, 2022
    Applicant: NOVEN PHARMACEUTICALS, INC.
    Inventor: Deboprosad Mondal
  • Benzosuberene analogues and related compounds with activity as anticancer agents
    Patent number: 10807932
    Abstract: A series of benzosuberene analogues demonstrate effective inhibition of tubulin polymerization, cytotoxicity against human cancer cell lines, and vascular disruption in tumors.
    Type: Grant
    Filed: August 16, 2019
    Date of Patent: October 20, 2020
    Assignee: BAYLOR UNIVERSITY
    Inventors: Kevin G. Pinney, Haichan Niu, Deboprosad Mondal
  • BENZOSUBERENE ANALOGUES AND RELATED COMPOUNDS WITH ACTIVITY AS ANTICANCER AGENTS
    Publication number: 20200055805
    Abstract: A series of benzosuberene analogues demonstrate effective inhibition of tubulin polymerization, cytotoxicity against human cancer cell lines, and vascular disruption in tumors.
    Type: Application
    Filed: August 16, 2019
    Publication date: February 20, 2020
    Applicant: Baylor University
    Inventors: Kevin G. Pinney, Haichan Niu, Deboprosad Mondal